Detalhe da pesquisa
1.
Early antibody therapy can induce long-lasting immunity to SHIV.
Nature
; 543(7646): 559-563, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28289286
2.
Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor.
Proc Natl Acad Sci U S A
; 117(36): 22436-22442, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820072
3.
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges.
Nature
; 533(7601): 105-109, 2016 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27120156
4.
Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains.
Proc Natl Acad Sci U S A
; 109(48): 19769-74, 2012 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129652
5.
Emergence of gp120 V3 variants confers neutralization resistance in an R5 simian-human immunodeficiency virus-infected macaque elite neutralizer that targets the N332 glycan of the human immunodeficiency virus type 1 envelope glycoprotein.
J Virol
; 87(15): 8798-804, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23720719
6.
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque.
Proc Natl Acad Sci U S A
; 108(50): 20125-9, 2011 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22123961
7.
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
J Virol
; 86(16): 8516-26, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22647691
8.
Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS.
J Virol
; 85(20): 10617-26, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813599
9.
High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections.
Proc Natl Acad Sci U S A
; 106(19): 8015-20, 2009 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19416840
10.
Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.
J Virol
; 84(9): 4769-81, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20147396
11.
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia.
J Exp Med
; 218(1)2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966579
12.
CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype.
J Virol
; 79(23): 14887-98, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16282488
13.
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies.
J Virol
; 76(5): 2123-30, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11836389
14.
Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.
Proc Natl Acad Sci U S A
; 100(25): 15131-6, 2003 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-14627745
15.
Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic.
J Virol
; 78(10): 5513-9, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15113931
16.
Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.
J Virol
; 77(20): 10829-40, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14512533
17.
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
J Virol
; 77(24): 13042-52, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14645561